Drugs / YHD001
last change Jan 2014 re-read 2 minutes ago

YHD001

Developed for
asthma · chronic bronchitis
Investigated by
Yuhan Corporation

Trials 2 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01424124 Nov 2011 → Jun 2013 asthma Yuhan Corporation Completed No outcome recorded
Phase 2 NCT01420445 Sep 2011 → May 2012 chronic bronchitis Yuhan Corporation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as YHD001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01420445
1

NCT01424124

Route Oral orally treated with YHD001” NCT01420445